WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) will be participating in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference, scheduled for October 8, 2024. This event gathers industry experts and companies to discuss advancements and trends in viral hepatitis treatment.
A key feature of the conference will be Arbutus Biopharma’s fireside chat, set for 1:30 pm ET. This session provides an opportunity for the company to share insights and updates on its progress and strategies in addressing viral hepatitis.
Interested parties can watch the live webcast of Arbutus’s presentation by visiting the company’s website. For those unable to attend the live session, an archived replay will be available for a limited time after the event.
The conference offers a platform for networking and one-on-one meetings with investors, alongside presentations by leading industry figures. It serves as a significant opportunity for stakeholders to engage with developments in viral hepatitis research and treatment.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.